Catherine Burzik Net Worth

The estimated Net Worth of Catherine M Burzik is at least $2.21 Million dollars as of 19 November 2021. Ms. Burzik owns over 1,660 units of Becton Dickinson & Co stock worth over $1,857,134 and over the last 13 years she sold BDX stock worth over $0. In addition, she makes $349,676 as Independent Director at Becton Dickinson & Co.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Burzik BDX stock SEC Form 4 insiders trading

Catherine has made over 3 trades of the Becton Dickinson & Co stock since 2018, according to the Form 4 filled with the SEC. Most recently she bought 1,660 units of BDX stock worth $50,248 on 19 November 2021.

The largest trade she's ever made was buying 1,660 units of Becton Dickinson & Co stock on 19 November 2021 worth over $50,248. On average, Catherine trades about 60 units every 33 days since 2011. As of 19 November 2021 she still owns at least 7,947 units of Becton Dickinson & Co stock.

You can see the complete history of Ms. Burzik stock trades at the bottom of the page.

Catherine Burzik biography

Catherine M. Burzik serves as Independent Director of the Company. From 2006 until the sale of the company in 2012, she served as President and Chief Executive Officer of Kinetic Concepts, Inc., a medical device company specializing in the fields of wound care and regenerative medicine. Prior thereto, she was President of Applied Biosystems and President of Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company. Ms. Burzik also is a director of Haemonetics Corporation. Ms. Burzik is a seasoned executive in the healthcare industry, having led major medical device, diagnostic, diagnostic imaging and life sciences businesses. She contributes strong strategic, product development and leadership expertise, and extensive knowledge of the global healthcare field.

What is the salary of Catherine Burzik?

As the Independent Director of Becton Dickinson & Co, the total compensation of Catherine Burzik at Becton Dickinson & Co is $349,676. There are 19 executives at Becton Dickinson & Co getting paid more, with Vincent Forlenza having the highest compensation of $16,014,600.

How old is Catherine Burzik?

Catherine Burzik is 69, she's been the Independent Director of Becton Dickinson & Co since 2013. There are 1 older and 31 younger executives at Becton Dickinson & Co. The oldest executive at Becton Dickinson & Co. is Marshall Larsen, 71, who is the Lead Independent Director.

What's Catherine Burzik's mailing address?

Catherine's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.

Insiders trading at Becton Dickinson & Co

Over the last 22 years, insiders at Becton Dickinson & Co have traded over $106,782,599 worth of Becton Dickinson & Co stock and bought 23,860 units worth $1,771,828 . The most active insiders traders include Edward J Ludwig, William M Brown, and Vincent A Forlenza. On average, Becton Dickinson & Co executives and independent directors trade stock every 20 days with the average trade being worth of $4,349,205. The most recent stock trade was executed by Roland Goette on 14 August 2024, trading 5,295 units of BDX stock currently worth $701,799.

What does Becton Dickinson & Co do?

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, and others.

Complete history of Ms. Burzik stock trades at Veradigm Inc, Orthofix Medical Inc, Becton Dickinson & Co, and Haemonetics

Becton Dickinson & Co executives and stock owners

Becton Dickinson & Co executives and other stock owners filed with the SEC include:

• Vincent Forlenza,
  Executive Chairman of the Board
• Patrick Kaltenbach,
  Executive Vice President, President - Life Sciences
• Thomas Polen,
  President, Chief Executive Officer, Chief Operating Officer, Director
• Christopher Reidy,
  Chief Financial Officer, Executive Vice President, Chief Administrative Officer
• Alberto Mas,
  Executive Vice President, President - Medical Segment
• Thomas E. Polen Jr.,
  Pres, CEO & Chairman
• Samrat Khichi,
  Executive Vice President - Public Policy and Regulatory Affairs
• Alexandre Conroy,
  Executive Vice President, Chief Integrated Supply Chain Officer
• Vincent A. Forlenza,
  Exec. Chairman
• Samrat S. Khichi,
  Exec. VP of Regulatory & Gov. Affairs and Gen. Counsel
• Alberto Mas,
  Exec. VP & Pres of the Medical Segment
• Samrat S. Khichi Esq.,
  Exec. VP of Corp. Devel., Public Policy & Regulatory Affairs and Gen. Counsel
• Christopher R. Reidy,
  Exec. VP, CFO & Chief Admin. Officer
• Simon D. Campion,
  Exec. VP & Pres of Interventional Segment
• Christopher DelOrefice,
  Exec. VP & CFO
• Marshall Larsen,
  Lead Independent Director
• Bertram Scott,
  Independent Director
• Claire Fraser,
  Independent Director
• Christopher Jones,
  Independent Director
• Catherine Burzik,
  Independent Director
• Claire Pomeroy,
  Independent Director
• Timothy Ring,
  Independent Director
• Rebecca Rimel,
  Independent Director
• David Melcher,
  Independent Director
• Jeffrey Henderson,
  Independent Director
• R. Andrew Eckert,
  Independent Director
• John DeFord,
  Executive Vice President, Chief Technology Officer
• James Lim,
  Executive Vice President, President, Greater Asia
• Thomas Spoerel,
  Chief Accounting Officer, Principal Accounting Officer, Vice President, Controller
• Monique Dolecki,
  Investor Relations Contact Officer
• Charles Bodner,
  Senior Vice President, Corporate Finance
• Roland Goette,
  Executive Vice President, President - EMEA
• Simon Campion,
  Executive Vice President and President, BD Interventional Segment
• Betty Larson,
  Executive Vice President- Human Resources, Chief Human Resources
• Denise Fleming,
  Exec. VP of Technology & Global Services and Chief Information Officer
• Francesca M. DeMartino,
  Sr. VP of Investor Relations
• Dr. Joseph M. Smith F.A.C.C, M.D., Ph.D.,
  Sr. VP, Chief Scientific Officer & Co-Chair of Scientific Advisory Board
• Troy Kirkpatrick,
  VP of PR
• Elizabeth McCombs,
  Exec. VP & Chief Technology Officer
• Michelle Quinn,
  Sr. VP and Chief Ethics & Compliance Officer
• Jerry Flasz,
  Exec. VP of Global Services & Chief Information Officer
• Dr. John A. DeFord,
  Exec. VP of R&D and CTO
• Thomas J. Spoerel,
  Sr. VP, Controller & Chief Accounting Officer
• Joanne Waldstreicher,
  Director
• Gary A Mecklenburg,
  Director
• John E Gallagher,
  VP, Corp Finance and Treasurer
• Linda M Tharby,
  Segment Pres. Life Sciences
• Wilard J Jr Overlock,
  Director
• Nabil Shabshab,
  Senior Vice President
• Jeffrey S Sherman,
  VP and General Counsel
• Basil Anderson,
  Director
• Ellen R Strahlman,
  Senior Vice President
• James F Orr,
  Director
• William A Tozzi,
  VP and Controller
• Gary M Cohen,
  President - BD Medical Systems
• Stephen Sichak,
  Senior Vice President
• Henry P Jr Becton,
  Director
• Carrie L Byington,
  Director
• Edward Degraan,
  Director
• William A Kozy,
  Pres - BD CLS and Cmpy Oper
• Alfred Sommer,
  Director
• David Shan,
  EVP and Chief ISC Officer
• Shana Carol Neal,
  EVP and Chief People Officer
• John P Groetelaars,
  EVP
• James W Borzi,
  EVP & Chief Supply Chain Offcr
• Suketu Upadhyay,
  Senior VP and Controller
• Adel Mahmoud,
  Director
• Jerome V Hurwitz,
  Senior Vice President
• Donna M Boles,
  Sr. Exec VP - Human Resources
• David V Elkins,
  Executive VP and CFO
• David T Durack,
  Senior Vice President
• William E. Rhodes,
  Senior Vice President
• Joseph Mercurio,
  VP and Corporate Controller
• Patricia B Shrader,
  Senior Vice President
• Scott P Bruder,
  SrVP; Chief Technology Officer
• Cathy E. Minehan,
  Director
• Margeretha Af Ugglas,
  Director
• Edward J Ludwig,
  Chairman, President and CEO
• James E Perrella,
  Director
• Alfred John Hanson,
  Executive Vice President
• John R Considine,
  Executive VP and CFO
• Jean Marc Dageville,
  VP - Human Resources
• Harry N Beaty,
  Director
• Frank Albert Olson,
  Director
• Bridget M Healy,
  VP, Gen Counsel and Secy
• Christopher Del Orefice,
  EVP & Chief Financial Officer
• Antoine C Ezell,
  EVP, President NA & CMO
• David Hickey,
  EVP & President, Life Sciences
• William M Brown,
  Director
• Rishi Grover,
  EVP and Chief ISC Officer
• Michael David Garrison,
  EVP & President Medical
• Richard Byrd,
  EVP & President Interventional
• Pavan Kumar Mocherla,
  EVP & President Greater Asia
• Michael Feld,
  EVP & President, Life Sciences